Cyclodextrins in delivery systems: Applications

被引:355
作者
Tiwari, Gaurav [1 ]
Tiwari, Ruchi [2 ]
Rai, Awani K. [2 ]
机构
[1] Jaipur Natl Univ, Jaipur, Rajasthan, India
[2] Pranveer Singh Inst Technol, Dept Pharmaceut, Kanpur, Uttar Pradesh, India
关键词
Complexation; transdermal; targeted drug delivery; colon; rectal;
D O I
10.4103/0975-7406.67003
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cyclodextrins (CDs) are a family of cyclic oligosaccharides with a hydrophilic outer surface and a lipophilic central cavity. CD molecules are relatively large with a number of hydrogen donors and acceptors and, thus in general, they do not permeate lipophilic membranes. In the pharmaceutical industry, CDs have mainly been used as complexing agents to increase aqueous solubility of poorly soluble drugs and to increase their bioavailability and stability. CDs are used in pharmaceutical applications for numerous purposes, including improving the bioavailability of drugs. Current CD-based therapeutics is described and possible future applications are discussed. CD-containing polymers are reviewed and their use in drug delivery is presented. Of specific interest is the use of CD-containing polymers to provide unique capabilities for the delivery of nucleic acids. Studies in both humans and animals have shown that CDs can be used to improve drug delivery from almost any type of drug formulation. Currently, there are approximately 30 different pharmaceutical products worldwide containing drug/CD complexes in the market.
引用
收藏
页码:72 / 79
页数:8
相关论文
共 68 条
[1]  
Aggarwal S, 2002, PHARMAZIE, V57, P191
[2]   Nasal absorption enhancement strategies for therapeutic peptides: an in vitro study using cultured human nasal epithelium [J].
Agu, RU ;
Dang, HV ;
Jorissen, M ;
Willems, T ;
Kinget, R ;
Verbeke, N .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 237 (1-2) :179-191
[3]   Mutual inhibition of the insulin absorption-enhancing properties of dodecylmaltoside and dimethyl-β-cyclodextrin following nasal administration [J].
Ahsan, F ;
Arnold, JJ ;
Meezan, E ;
Pillion, DJ .
PHARMACEUTICAL RESEARCH, 2001, 18 (05) :608-614
[4]   Study on the inclusion complexes of bromazepam with β- and β-hydroxypropyl-cyclodextrins [J].
Archontaki, HA ;
Vertzoni, MV ;
Athanassiou-Malaki, MH .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2002, 28 (3-4) :761-769
[5]   Study of omeprazole-γ-cyclodextrin complexation in the solid state [J].
Arias, MJ ;
Moyano, JR ;
Muñoz, P ;
Ginés, JM ;
Justo, A ;
Giordano, F .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2000, 26 (03) :253-259
[6]   Comparative studies of the enhancing effects of cyclodextrins on the solubility and oral bioavailability of tacrolimus in rats [J].
Arima, H ;
Yunomae, K ;
Miyake, K ;
Irie, T ;
Hirayama, F ;
Uekama, K .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2001, 90 (06) :690-701
[7]   Enhancing effect of hydroxypropyl-β-cyclodextrin on cutaneous penetration activation of ethyl 4-biphenylyl acetate in hairless mouse skin [J].
Arima, H ;
Miyaji, T ;
Irie, T ;
Hirayama, F ;
Uekama, K .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 1998, 6 (01) :53-59
[8]   The effects of water-soluble cyclodextrins on the histological integrity of the rat nasal mucosa [J].
Asai, K ;
Morishita, M ;
Katsuta, H ;
Hosoda, S ;
Shinomiya, K ;
Noro, M ;
Nagai, T ;
Takayama, K .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 246 (1-2) :25-35
[9]  
Baboota S, 2003, PHARMAZIE, V58, P73
[10]  
Baboota S, 2003, INDIAN J PHARM SCI, V64, P408